Abbott Libre refers to a family of continuous glucose monitoring products manufactured by Abbott Diabetes Care. The line includes prescription devices for people with diabetes (FreeStyle Libre 2 Plus and Libre 3) and an over-the-counter biosensor for wellness use (Lingo). All use a factory-calibrated enzyme electrode sensor worn on the back of the upper arm.
Overview of the Abbott Libre Line
Abbott first launched FreeStyle Libre in Europe in 2014 and in the United States in 2017 as a flash glucose monitor, where users scanned a reader over the sensor to retrieve data. Later generations moved to continuous Bluetooth streaming. The current portfolio in the US is:
- FreeStyle Libre 2 Plus: Real-time alerts, 15-day wear, compatible with automated insulin delivery systems.
- FreeStyle Libre 3: Smallest on-body sensor, 1-minute updates, 14-day wear.
- Lingo: OTC biosensor for wellness, 14-day wear, no hypoglycemia alerts.
How the Sensor Works
Each Libre sensor uses a glucose oxidase enzyme electrode similar in principle to other CGMs. A thin flexible filament is inserted 5 mm under the skin on the back of the upper arm using a single-motion applicator. The enzyme reacts with glucose in interstitial fluid, generating a current converted to a mg/dL value by the on-sensor electronics.
Unlike Dexcom, the Libre line integrates the sensor and transmitter into a single disposable unit, simplifying setup but meaning the entire device is thrown away after 14-15 days.
Accuracy
| Device | MARD | Wear | Data update | Alerts |
|---|---|---|---|---|
| FreeStyle Libre 2 Plus | ~9.0% | 15 days | 1 minute | Hypo/hyper alarms |
| FreeStyle Libre 3 | ~7.9% | 14 days | 1 minute | Hypo/hyper alarms |
| Lingo (OTC) | ~10% | 14 days | 1 minute | Wellness only, no medical alarms |
Libre 3’s mean absolute relative difference (MARD) of approximately 7.9% is among the lowest of any commercially available CGM, indicating strong agreement with laboratory reference values across the full glucose range.
Who Should Use Which Libre Product
FreeStyle Libre 2 Plus and Libre 3 are indicated for adults and children aged 4 and older with diabetes. They are particularly helpful for people on multiple daily insulin injections, insulin pumps, or high-risk non-insulin therapies. Both integrate with certain automated insulin delivery systems and compatible insulin pens.
Lingo targets adults without diabetes who want to observe glucose patterns related to food, exercise, stress, and sleep as part of a wellness routine or alongside a prediabetes diet plan. It does not include hypoglycemia alerts because its users are not expected to be at risk.
Insurance Coverage
Medicare covers FreeStyle Libre 2, 2 Plus, and 3 for people with diabetes meeting the program’s criteria, which now include many people on any form of insulin. Most commercial insurers also cover the prescription Libre products under pharmacy or durable medical equipment benefits. Lingo is not reimbursed and is purchased out of pocket.
Setting Up and Wearing a Sensor
- Clean the back of the upper arm with alcohol and let it dry.
- Remove the applicator cap, press firmly against the skin, and release to deploy the sensor.
- Open the app and scan or tap to pair the new sensor.
- Wait 60 minutes for warm-up before readings appear.
- Wear during showering and most exercise. Avoid hot tubs and prolonged submersion.
Troubleshooting Common Issues
- Sensor falls off early: Use an overpatch in hot, humid climates or during heavy exercise.
- Inaccurate reading suspected: Confirm with a fingerstick, especially if symptoms do not match the number.
- No data in app: Check Bluetooth, app permissions, and that your phone is within 33 feet of the sensor.
- Skin irritation: Try barrier films or rotate insertion sites between arms.
How Libre Fits Into Care
CGM data helps clinicians adjust medication, identify unrecognized nocturnal lows, and personalize treatment plans. The FDA has cleared Libre 2 Plus and Libre 3 for integrated continuous glucose monitoring (iCGM), a category signifying high accuracy and interoperability with automated insulin delivery.
The Bottom Line
Abbott Libre is a strong choice of CGM family, offering some of the most accurate factory-calibrated sensors on the market, a 14-15 day wear time, and options for both clinical diabetes management and OTC wellness use. Libre 3 leads the line on accuracy and convenience. Work with your clinician to decide which product fits your diagnosis, insurance situation, and treatment goals, and do not use CGM data to make major medication changes without professional input.
